UNICA IRIS Institutional Research Information System

COCCO, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 494.223
NA - Nord America 27.147
AS - Asia 11.943
SA - Sud America 1.886
Continente sconosciuto - Info sul continente non disponibili 1.395
AF - Africa 301
OC - Oceania 30
Totale 536.925
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 486.862
US - Stati Uniti d'America 26.671
SG - Singapore 4.702
CN - Cina 3.850
BR - Brasile 1.441
SE - Svezia 1.274
UA - Ucraina 1.265
NL - Olanda 1.248
VN - Vietnam 1.101
DE - Germania 895
FI - Finlandia 714
GB - Regno Unito 681
FR - Francia 609
HK - Hong Kong 439
BD - Bangladesh 408
CA - Canada 265
IN - India 265
KR - Corea 186
AR - Argentina 154
TR - Turchia 120
IQ - Iraq 115
JP - Giappone 110
MX - Messico 103
RU - Federazione Russa 102
ZA - Sudafrica 95
AT - Austria 81
ES - Italia 81
PL - Polonia 75
PK - Pakistan 74
ID - Indonesia 66
MA - Marocco 65
EC - Ecuador 63
CO - Colombia 61
UZ - Uzbekistan 56
VE - Venezuela 54
BE - Belgio 53
PH - Filippine 52
IR - Iran 49
SA - Arabia Saudita 49
CL - Cile 39
CZ - Repubblica Ceca 36
MY - Malesia 34
IE - Irlanda 33
IL - Israele 30
LT - Lituania 27
AE - Emirati Arabi Uniti 26
EU - Europa 25
TN - Tunisia 25
AU - Australia 24
AZ - Azerbaigian 24
JO - Giordania 24
KE - Kenya 24
EG - Egitto 23
JM - Giamaica 23
DZ - Algeria 22
CR - Costa Rica 20
NP - Nepal 20
UY - Uruguay 20
GR - Grecia 19
RO - Romania 19
PY - Paraguay 18
CH - Svizzera 17
PE - Perù 16
TH - Thailandia 16
BO - Bolivia 15
OM - Oman 15
PT - Portogallo 15
AL - Albania 14
HR - Croazia 14
KZ - Kazakistan 14
PS - Palestinian Territory 14
TW - Taiwan 14
DK - Danimarca 11
GT - Guatemala 11
HU - Ungheria 11
BG - Bulgaria 10
DO - Repubblica Dominicana 10
LB - Libano 10
RS - Serbia 10
CI - Costa d'Avorio 9
ET - Etiopia 9
KG - Kirghizistan 9
KW - Kuwait 9
PA - Panama 8
EE - Estonia 7
MD - Moldavia 7
GE - Georgia 6
NG - Nigeria 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
BH - Bahrain 5
CY - Cipro 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
PR - Porto Rico 5
SV - El Salvador 5
BB - Barbados 4
GY - Guiana 4
Totale 535.478
Salva come PNG Salva come JPEG
Città #
Cagliari 473.841
Uta 10.670
Ashburn 2.543
Singapore 2.384
Fairfield 2.335
Woodbridge 1.769
San Jose 1.445
Dallas 1.251
Chandler 1.197
Houston 1.129
Boardman 1.106
Amsterdam 1.102
Wilmington 984
Seattle 951
Ann Arbor 829
Cambridge 780
Beijing 723
Nyköping 710
Los Angeles 612
Council Bluffs 604
Jacksonville 594
Helsinki 466
New York 437
Hong Kong 398
Chicago 366
Dearborn 365
Santa Clara 348
Lauterbourg 331
The Dalles 322
Ho Chi Minh City 313
Munich 291
Nanjing 287
Shanghai 277
Boston 264
Hefei 257
Buffalo 237
Hanoi 235
Milan 219
Rome 189
Seoul 175
Salt Lake City 147
San Diego 141
Guangzhou 131
São Paulo 126
Dong Ket 122
Columbus 117
London 116
Atlanta 114
Toronto 109
Orem 103
Shenyang 100
Norwalk 98
Nanchang 96
Phoenix 90
Redwood City 90
Redondo Beach 83
Tokyo 83
Elk Grove Village 81
Jiaxing 80
Brooklyn 77
Frankfurt am Main 76
Washington 76
Tampa 72
Hebei 71
Sassari 71
Changsha 63
Montreal 61
Tianjin 61
Warsaw 58
Da Nang 54
Denver 54
Verona 54
Johannesburg 53
Nuremberg 53
Tashkent 49
Baghdad 45
Stockholm 45
Miami 44
Rio de Janeiro 43
Vienna 43
Detroit 42
Jinan 42
Mexico City 41
San Francisco 41
Chennai 40
Shenzhen 40
Hangzhou 39
Istanbul 39
Sterling 39
Naples 38
Turku 37
Brussels 36
Mountain View 36
Zhengzhou 36
Düsseldorf 34
Haiphong 33
Dublin 32
Manchester 31
Turin 31
Curitiba 30
Totale 517.323
Salva come PNG Salva come JPEG
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.165
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.994
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.253
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.947
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.590
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.507
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.498
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.413
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.314
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.225
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.221
Overexpression of the cytokine BAFF and autoimmunity risk 4.141
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.056
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.026
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.992
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.943
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.904
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.848
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.846
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.832
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.807
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.736
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.716
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.672
Walking improvements with nabiximols in patients with multiple sclerosis 3.655
Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals 3.625
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.624
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.618
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.602
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.594
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.520
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.446
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.414
Impact of the media on future hope in multiple sclerosis 3.394
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.325
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.319
Multiple Sclerosis and environmental factors. 3.300
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.300
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.298
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.245
Oral agents in multiple sclerosis 3.217
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.215
Influence of treatments in multiple sclerosis disability: a cohort study 3.193
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.170
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.153
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.124
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.111
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.107
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study 3.076
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.065
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.054
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 3.003
Refining the connection between gait and cognition: training the body to improve the brain 2.990
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.988
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.984
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.982
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.965
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.957
Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis 2.925
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.888
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.880
Hourly trends of physical activity in people with Multiple Sclerosis 2.868
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.821
Do gait patterns differ in men and women with multiple sclerosis? 2.809
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.732
Postural adaptation during a Nintendo Wii balance training 2.676
Perception of risk and shared decision making process in multiple sclerosis 2.659
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.649
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.645
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.632
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.618
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.609
The relationships between physical activity, self-efficacy, and quality of life in people with multiple sclerosis 2.600
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.579
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.564
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.543
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.493
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.457
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.414
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.344
The cohort of the multiple sclerosis center of Cagliari 2.340
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.336
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.323
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.311
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.295
Induction and escalation therapies in multiple sclerosis 2.291
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.279
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.261
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.250
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.242
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.230
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.213
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.108
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.107
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.075
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.068
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.061
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.059
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.040
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.030
Totale 316.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 691.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 691.724
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202222.649 0 1.763 1.115 2.039 2.209 1.580 1.217 1.264 2.468 2.858 3.383 2.753
2022/202336.235 3.108 5.156 5.038 3.231 3.069 3.597 1.763 2.760 2.009 2.109 2.761 1.634
2023/202438.874 2.396 1.901 1.510 2.537 3.741 6.434 5.206 3.347 1.961 2.893 3.507 3.441
2024/202598.907 28.032 28.966 11.450 8.286 4.316 4.788 6.787 483 1.114 1.990 1.689 1.006
2025/202626.459 1.758 1.093 2.417 2.373 1.798 1.840 5.513 2.191 1.870 2.380 1.916 1.310
2026/20272.110 834 1.276 0 0 0 0 0 0 0 0 0 0
Totale 536.925